June - 2020
| Previous Next | Showing Journal 3 of 4 |
Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquinePeter Horby and Martina Landray, Chief Investigators if the RECOVERY Trial Statement from Investigators, 2020, June 2020 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
June |
Previous Comments
No Comments yet.
Comment
The RECOVERY trial is a large factorial assignment RCT aiming to enrol 12,000 particiapnts with COVID-19, and assess the effect of Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids,...